Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.500
-0.860 (-36.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.850
+0.350 (23.33%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Tvardi Therapeutics Stock Forecast
TVRD's stock price has decreased by -94.47% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Tvardi Therapeutics stock have an average target of 8.29, with a low estimate of 3.00 and a high estimate of 15. The average target predicts an increase of 452.67% from the current stock price of 1.50.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tvardi Therapeutics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $9 | Buy | Initiates | $9 | +500.00% | Jun 24, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $12 | Buy | Reiterates | $12 | +700.00% | May 12, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +566.67% | May 11, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
| Barclays | Barclays | Sell Reiterates $3 | Sell | Reiterates | $3 | +100.00% | May 8, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.39
from -2.46
EPS Next Year
-2.89
from -2.39
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.72 | -0.56 | |
| Avg | -2.39 | -2.89 | |
| Low | -3.54 | -6.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.